INVO Bioscience, Inc. (IVOB) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated March 30, 2020, reports the issuance of a press release by INVO Bioscience, Inc. (formerly INVO Fertility, Inc.) announcing financial results for the fiscal year ended December 31, 2019. The company is incorporated in Nevada and trades on the OTCMKTS under the symbol IVOB.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the text of this 8-K.
Material Changes
The filing does not provide specific data to compare current period results against prior comparable periods. The document serves solely as a notification that the annual results for 2019 have been released.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies. The document explicitly states that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 30, 2020) for actual financial figures for the year ended December 31, 2019.
- Verify the company's current legal name status, as the filing header lists "INVO Bioscience, Inc." while the request metadata references "INVO Fertility, Inc."
- Confirm the trading status and liquidity of the stock on the OTCMKTS given the lack of detailed financial data in this specific filing.
- Check subsequent filings for any updates on the company's operational status or capital position following the 2019 results.